8-A12B

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Fibrocell Science, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   87-0458888

(State

of Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

405 Eagleview Boulevard

Exton, Pennsylvania

  19341
(Address of Principal Executive Offices)   (Zip Code)

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Common Stock, par value $0.001 per share   NYSE MKT LLC

 

 

If this form relates to the registration of a securities pursuant to Section 12(b) of the Exchange Act and is effective upon filing pursuant to General Instruction A.(c), please check the following box.    x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.    ¨

 

Securities Act registration statement file number to which this form relates:                                  
   (If applicable)   

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 


Item 1. Description of Registrant’s Securities to be Registered.

Fibrocell Science, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock, par value $0.001 per share (the “Common Stock”), to be registered hereunder contained under the heading “Description of Securities” in the Registrant’s Registration Statement on Form S-3 (File No. 333-185466), as originally filed with the Securities and Exchange Commission (the “Commission”) on January 11, 2013 (the “Registration Statement”) and declared effective by the Commission on January 22, 2013. Any form of prospectus to the Registration Statement that includes such description and that is subsequently filed is also incorporated by reference herein.

 

Item 2. Exhibits.

The Common Stock to be registered on this Form 8-A is to be listed on the NYSE MKT LLC. In accordance with the instructions to Form 8-A, no exhibits are required to be filed as part of this Form 8-A because no other securities of the Registrant are registered on the NYSE MKT LLC and because the securities being registered on this Form 8-A are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

Dated: May 14, 2013

 

Fibrocell Science, Inc.
By:   /s/ David Pernock
  David Pernock, Chief Executive Officer